Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 39451-39500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05876715
LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma
PHASE1/PHASE2Recruiting
40 participants
Started: Jun 7, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06586710
Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLE
NARecruiting
60 participants
Started: Jun 7, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06222242
mychoiceTM Implementation With Medical Oncology Patients
NARecruiting
200 participants
Started: Jun 7, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05916911
Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
PHASE4Recruiting
120 participants
Started: Jun 7, 2023 · Completed: Jan 8, 2025
3 conditions2 sponsors4 locations
NCT06152471
Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer
PHASE3Recruiting
100 participants
Started: Jun 7, 2023 · Completed: Mar 31, 2025
3 conditions1 sponsor7 locations
NCT06110520
Violet Light for the Suppression of Myopia
NARecruiting
72 participants
Started: Jun 7, 2023 · Completed: Mar 1, 2026
2 conditions1 sponsor1 location
NCT05887102
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
NARecruiting
66 participants
Started: Jun 7, 2023 · Completed: Mar 31, 2025
2 conditions3 sponsors1 location
NCT05883852
EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
PHASE3Recruiting
1,406 participants
Started: Jun 7, 2023 · Completed: Jul 1, 2031
1 condition1 sponsor1 location
NCT06349720
Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
N/ARecruiting
17,000 participants
Started: Jun 7, 2023 · Completed: Jun 7, 2024
1 condition1 sponsor1 location
NCT05558514
Place-based Cochlear Implant Mapping
NARecruiting
30 participants
Started: Jun 7, 2023 · Completed: May 31, 2026
2 conditions4 sponsors1 location
NCT05852041
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
EARLY_PHASE1Recruiting
40 participants
Started: Jun 7, 2023 · Completed: Jun 7, 2035
4 conditions2 sponsors1 location
NCT05883462
Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH)
EARLY_PHASE1Recruiting
45 participants
Started: Jun 7, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05256745
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
PHASE1/PHASE2Recruiting
48 participants
Started: Jun 6, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor3 locations
NCT06125327
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
PHASE2/PHASE3Recruiting
210 participants
Started: Jun 6, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05837585
The Effectiveness of Air Quality Sensor in Elderly Residential Setting
NARecruiting
60 participants
Started: Jun 6, 2023 · Completed: Jan 31, 2024
2 conditions3 sponsors1 location
NCT05810480
PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin G
N/ARecruiting
200 participants
Started: Jun 6, 2023 · Completed: Jan 31, 2027
2 conditions1 sponsor8 locations
NCT05195905
PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm
NARecruiting
30 participants
Started: Jun 6, 2023 · Completed: Aug 31, 2029
2 conditions1 sponsor2 locations
NCT05806164
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
PHASE4Recruiting
432 participants
Started: Jun 6, 2023 · Completed: Aug 1, 2030
1 condition7 sponsors5 locations
NCT05833217
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
NARecruiting
55 participants
Started: Jun 6, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor2 locations
NCT05894057
Acceptability of Various Available Midazolam Formulations (Syrup, Rectal Suppository, Oro-dispersible Minitablet) in Clinical Practice
N/ARecruiting
100 participants
Started: Jun 6, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT04123431
ACE Acetabular Cup UK Multi-centre PMCF Study
N/ARecruiting
225 participants
Started: Jun 6, 2023 · Completed: Nov 30, 2035
1 condition1 sponsor1 location
NCT05924581
Validation of Clinical Assessment of Spinal Stiffness
NARecruiting
25 participants
Started: Jun 6, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05793801
Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia
NARecruiting
60 participants
Started: Jun 6, 2023 · Completed: Sep 1, 2027
1 condition2 sponsors1 location
NCT06666881
Skeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in HNSCC Patients
NARecruiting
60 participants
Started: Jun 6, 2023 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT06030830
SMaRT Mom - Smartphone Management and Responsive Time for Breastfeeding Mothers
NARecruiting
100 participants
Started: Jun 6, 2023 · Completed: Oct 31, 2025
4 conditions1 sponsor1 location
NCT05636787
Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients
PHASE2Recruiting
120 participants
Started: Jun 6, 2023 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT05789316
Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)
NARecruiting
60 participants
Started: Jun 6, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05665660
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening
NARecruiting
350 participants
Started: Jun 6, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05246644
IV Acetaminophen After Cardiac Surgery - PILOT
PHASE3Recruiting
900 participants
Started: Jun 6, 2023 · Completed: Dec 15, 2024
1 condition4 sponsors2 locations
NCT06078982
Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer
PHASE1Recruiting
39 participants
Started: Jun 6, 2023 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT05894421
TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
PHASE1Recruiting
92 participants
Started: Jun 6, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor11 locations
NCT06078683
Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function
NARecruiting
30 participants
Started: Jun 6, 2023 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT07089030
Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy
NARecruiting
20 participants
Started: Jun 6, 2023 · Completed: Jun 6, 2026
3 conditions1 sponsor1 location
NCT05545306
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
NARecruiting
120 participants
Started: Jun 6, 2023 · Completed: Feb 2, 2027
3 conditions1 sponsor1 location
NCT05813457
Impact of an Early Identification Program for First-Episode Psychosis on the Duration of Untreated Psychosis
NARecruiting
416 participants
Started: Jun 6, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor6 locations
NCT05768035
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide
PHASE1/PHASE2Recruiting
40 participants
Started: Jun 6, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor4 locations
NCT06068257
Tumor-Derived FGF19
N/ARecruiting
210 participants
Started: Jun 6, 2023 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT05537662
External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)
NARecruiting
30 participants
Started: Jun 6, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05762952
Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
PHASE1Recruiting
40 participants
Started: Jun 6, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05948865
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
102 participants
Started: Jun 6, 2023 · Completed: Dec 12, 2025
2 conditions1 sponsor13 locations
NCT05642611
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
PHASE3Recruiting
777 participants
Started: Jun 6, 2023 · Completed: Aug 30, 2031
1 condition2 sponsors29 locations
NCT05567289
Precision Medicine for Stem Cell Transplantation
N/ARecruiting
300 participants
Started: Jun 6, 2023 · Completed: Aug 31, 2028
1 condition2 sponsors3 locations
NCT05942248
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
NARecruiting
150 participants
Started: Jun 6, 2023 · Completed: Feb 28, 2025
4 conditions2 sponsors1 location
NCT05880537
Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
N/ARecruiting
100 participants
Started: Jun 6, 2023 · Completed: Dec 15, 2027
1 condition1 sponsor4 locations
NCT05966454
Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure - UCSF
PHASE4Recruiting
145 participants
Started: Jun 6, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06302062
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
PHASE1Recruiting
23 participants
Started: Jun 6, 2023 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06317818
Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease?
PHASE2Recruiting
50 participants
Started: Jun 6, 2023 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT06289244
Correlation Between Muscle Strength and Thickness in Critically Ill Patients
N/ARecruiting
50 participants
Started: Jun 6, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06889883
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
N/ARecruiting
510 participants
Started: Jun 6, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor9 locations
NCT05058183
Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer
NARecruiting
400 participants
Started: Jun 5, 2023 · Completed: Dec 5, 2028
1 condition3 sponsors2 locations